# Glide Pharmaceutical Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glide-pharmaceutical-technologies

- Industry: Pharmaceuticals
- Headquarters: Abingdon, UK
- Website: www.glide-technologies.com
- Total disclosed funding: $3.6M
- Latest round: Series A (Dec 1, 2005)
- Investors on record: 2

## About

Glide Pharmaceutical Technologies Limited develops innovative software solutions for the pharmaceutical industry, focusing on enhancing operational efficiency and user engagement through advanced technology.Founded in 2001, Glide Pharmaceutical Technologies Limited operates out of Abingdon, UK, providing specialized software solutions. The firm has engaged in 10 deals, with its most recent funding round occurring in February 2017 when it raised GBP 3.2 million from investors including Hygea VCT PLC, Invesco Perpetual, Oxford Capital Partners, and Oxford Technology Management. The company has not undergone any noted pivots or changes in its core business strategy.Glide Technologies specializes in providing Software as a Service (SaaS) solutions that empower businesses to optimize their operations and enhance user engagement. The company’s core offerings focus on streamlining workflow processes through innovative software tools tailored to various industries. These solutions facilitate tasks such as project management, data analytics, and customer relationship management, allowing clients to improve efficiency and decision-making capabilities. Glide Technologies serves a diverse client base, including small to medium-sized enterprises and large corporations, across multiple geographical markets including North America, Europe, and Asia-Pacific.Glide Technologies generated revenue of GBP 0 in the most recent year, 2016, with an EBITDA loss of GBP -3,950,572.4. The company primarily relies on subscription-based models, structuring transactions as B2B agreements where businesses subscribe to different service tiers based on their needs. Among its flagship products, Glide Technologies offers comprehensive analytics and reporting tools integral to client workflows, providing essential insights for business growth.In February 2017, Glide Pharmaceutical Technologies Limited raised GBP 3.2 million in venture funding to support the development of new products and expand into new markets. The company plans to launch innovative software solutions within the next year and aims to enter additional geographical regions, including Asia-Pacific and North America, by the end of 2018. The recent funding will specifically be utilized to enhance product offerings and establish a stronger market presence.

## Funding rounds

- Series A, Dec 1, 2005, $3.6M — Oxford Technology Management, Oxford Investment Opportunity Network

## Investors

- Oxford Technology Management (https://capitalatlas.ai/funds/oxford-technology-management) — Series A
- Oxford Investment Opportunity Network — Series A